Release the supported conclusion

A defensible toxicology inventory prevents specific failures: the target panel and cutoff prevent overreading a class result; lot, calibrator, and software preserve traceability; hydrolysis states whether free or total analyte was measured; reflex rules prevent the wrong confirmation path; and report wording preserves presumptive versus definitive status.

Clinical and forensic toxicology are not interchangeable workflows. CLIA-covered clinical testing requires written specimen identification, integrity, and handling procedures. A forensic chain of custody additionally documents possession transfers, seals, and tamper evidence, while forensic positives require the applicable validated confirmation and review process.

In federally regulated workplace testing, an MRO reviews results and possible legitimate medical explanations before verification. That role and the federal cutoff set are not automatically part of clinical toxicology. Local policy must declare the panel, cutoff, analyzer, reagent lot, calibrator, software, hydrolysis choice, reflex rules, turnaround time, and report language.

Release the analyte-specific finding and its method boundary, not an unsupported story about the person. Identify whether the program is clinical or forensic. Declare local policy fields that affect the report.